Genocea Biosciences (NASDAQ:GNCA) Earns Sell Rating from Analysts at StockNews.com
Research analysts at StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a report released on Wednesday. The brokerage set a “sell” rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of […]
Research analysts at StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a report released on Wednesday. The brokerage set a “sell” rating on the biotechnology company’s stock. Genocea Biosciences Stock Performance The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of […]
